Evidence map›Paper›PMID 29212705›Full record

ArticleJournal of clinical microbiology2018

Update from a 12-Year Nationwide Fungemia Surveillance: Increasing Intrinsic and Acquired Resistance Causes Concern.

K M T Astvad, H K Johansen, B L Røder, F S Rosenvinge, J D Knudsen, L Lemming, H C Schønheyder, R K Hare, L Kristensen, L Nielsen and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed, 1 pooled it
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 1 synthesis or guideline pooled it, 121 citations in OpenAlex.

  1. Pooled it
  2. Changes in age composition and epidemiology of candidaemia, Iceland, 2012 to 2023.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026
    Article
  3. Review
  4. Pediatric reports · 2026
    Article
  5. Article
  6. BeyondJournal of fungi (Basel, Switzerland) · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Anti-Pharmaceutics · 2025
    Article
  11. Review
  12. Susceptibility patterns ofInfection prevention in practice · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Ibrexafungerp: A narrative overview.Current research in microbial sciences · 2024
    Review
  17. Article
  18. Article
  19. Article
  20. Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 10 institutions in 1 country.

K M T AstvadUnit of Mycology, Statens Serum Institut, Copenhagen, Denmark.
H K JohansenDepartment of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark.
B L RøderDepartment of Clinical Microbiology, Slagelse Hospital, Slagelse, Denmark.
F S RosenvingeDepartment of Clinical Microbiology, Odense University Hospital, Odense, Denmark.
J D KnudsenDepartment of Clinical Microbiology, Hvidovre University Hospital, Copenhagen, Denmark.
L LemmingDepartment of Clinical Microbiology, Aarhus University Hospital, Aarhus, Denmark.
H C SchønheyderDepartment of Clinical Microbiology, Aalborg University Hospital, Aalborg, Denmark.ORCID 0000-0002-7599-4658
R K HareUnit of Mycology, Statens Serum Institut, Copenhagen, Denmark.ORCID 0000-0002-9796-023X
L KristensenDepartment of Clinical Microbiology, Aarhus University Hospital, Aarhus, Denmark.
L NielsenDepartment of Clinical Microbiology, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.
J B GertsenDepartment of Clinical Microbiology, Aarhus University Hospital, Aarhus, Denmark.
E DzajicDepartment of Clinical Microbiology, Sydvestjysk Sygehus, Esbjerg, Denmark.
M PedersenDepartment of Clinical Microbiology, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.
C ØstergårdDepartment of Clinical Microbiology, Lillebaelt Hospital, Vejle, Denmark.
B OlesenDepartment of Clinical Microbiology, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.
T S SøndergaardDepartment of Clinical Microbiology, Hospital of Southern Jutland, Sønderborg, Denmark.
M C ArendrupUnit of Mycology, Statens Serum Institut, Copenhagen, Denmark maca@ssi.dk.
University of Copenhagen · DKAarhus University Hospital · DKStatens Serum Institut · DKAalborg University Hospital · DKHospital South West Jutland · DKHvidovre Hospital · DKLillebaelt Hospital · DKOdense University Hospital · DKSlagelse Hospital · DKSygehus Sønderjylland · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

New data from the years 2012 to 2015 from the Danish National Fungemia Surveillance are reported, and epidemiological trends are investigated in a 12-year perspective (2004 to 2015). During 2012 to 2015, 1,900 of 1,939 (98%) fungal bloodstream isolates were included. The average incidence was 8.4/100,000 inhabitants, and this appears to represent a stabilizing trend after the increase to 10.1/100,000 in 2011. The incidence was higher in males than females (10.0 versus 6.8) and in patients above 50 years, and those changes were mainly driven by an increasing incidence among 80-to-89-year-old males (65.3/100,000 in 2014 to 2015). The proportion of

Indexed as

Epidemiological MonitoringAgedAged, 80 and overAge FactorsAmphotericin BAntifungal AgentsCandidaCandida albicansCandida glabrataDenmarkDrug Resistance, Multiple, FungalEchinocandinsFemaleFluconazoleFungemiaHumansAmphotericin BAntifungal Agentsechinocandin CEchinocandinsFluconazoleItraconazoleantifungal consumptionazole resistanceCandida glabratacandidemiaechinocandin resistanceepidemiologyfungemiamultidrug resistancepopulation-basedsurveillance

Identifiers

PMID29212705
PMCPMC5869841
OpenAlexW2773217499

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.